Physician profile
Marjorie E Beams
NPI 1144640202
$1,060.24
in general payments reported to CMS, 2019-2025
18 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.36 · 2021: $112 · 2022: $12.97 · 2023: $19.38 · 2024: $453 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $180.70 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $158.20 | 2024-2025 | |
| Novo Nordisk INC | $157.59 | 2024-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $120.95 | 2025 | Kisunla, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $95.34 | 2024-2025 | Farxiga, Breztri |
| Boston Scientific Corporation | $42.14 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $39.25 | 2024-2025 | Rexulti |
| Alkermes, INC. | $36.83 | 2024 | Vivitrol |
| Exact Sciences Corporation | $34.44 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Indivior INC. | $25.83 | 2025 | Sublocade |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.67 | 2025 | Jardiance |
| Allergan, INC. | $25.36 | 2020 | |
| Medtronic, INC. | $25.23 | 2024 | Venaseal |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.19 | 2025 | Caplyta |
| Sumitomo Pharma America, INC. | $20.85 | 2025 | Gemtesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $17.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.46 | 2024 | Eliquis |
| Abbott Laboratories | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Beams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.